Abstract:IMPORTANCE It is unclear whether physiotherapy and occupational therapy are clinically effective and cost-effective in Parkinson disease (PD). OBJECTIVE To perform a large pragmatic randomized clinical trial to evaluate the clinical effectiveness of individualized physiotherapy and occupational therapy in PD. DESIGN, SETTING, AND PARTICIPANTS The PD REHAB Trial was a multicenter, open-label, parallel group, controlled efficacy trial. A total of 762 patients with mild to moderate PD were recruited from 38 sites across the United Kingdom. Recruitment took place between October 2009 and June 2012, with 15 months of follow-up. INTERVENTIONS Participants with limitations in activities of daily living (ADL) were randomized to physiotherapy and occupational therapy or no therapy. MAIN OUTCOMES AND MEASURES The primary outcome was the Nottingham Extended Activities of Daily Living (NEADL) Scale score at 3 months after randomization. Secondary outcomes were health-related quality of life (assessed by Parkinson Disease Questionnaire-39 and EuroQol-5D); adverse events; and caregiver quality of life. Outcomes were assessed before trial entry and then 3, 9, and 15 months after randomization. RESULTS Of the 762 patients included in the study (mean [SD] age, 70 [9.1] years), 381 received physiotherapy and occupational therapy and 381 received no therapy. At 3 months, there was no difference between groups in NEADL total score (difference, 0.5 points; 95% CI, -0.7 to 1.7; P = .41) or Parkinson Disease Questionnaire-39 summary index (0.007 points; 95% CI, -1.5 to 1.5; P = .99). The EuroQol-5D quotient was of borderline significance in favor of therapy (-0.03; 95% CI, -0.07 to -0.002; P = .04). The median therapist contact time was 4 visits of 58 minutes over 8 weeks. Repeated-measures analysis showed no difference in NEADL total score, but Parkinson Disease Questionnaire-39 summary index (diverging 1.6 points per annum; 95% CI, 0.47 to 2.62; P = .005) and EuroQol-5D score (0.02; 95% CI, 0.00007 to 0.03; P = .04) showed small differences in favor of therapy. There was no difference in adverse events. CONCLUSIONS AND RELEVANCE Physiotherapy and occupational therapy were not associated with immediate or medium-term clinically meaningful improvements in ADL or quality of life in mild to moderate PD. This evidence does not support the use of low-dose, patient-centered, goal-directed physiotherapy and occupational therapy in patients in the early stages of PD. Future research should explore the development and testing of more structured and intensive physical and occupational therapy programs in patients with all stages of PD. TRIAL REGISTRATION isrctn.org Identifier: ISRCTN17452402.

Research progress of radiation-induced heart injury——clinical

Protective Role of Shenmai Injection on Radiation-Induced Heart Injury

Research Progress on Cardiac Injury from Breast Cancer Radiation Therapy

Preclinical research into basic mechanisms of radiation-induced heart disease

Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update

Relationship Between Heart Irradiation Dose-volume and Radiation-induced Cardiac Toxicity in Radiotherapy for Thoracic Neoplasms

Advancements in Radiation-Induced Heart Disease Diagnosis and Treatment

Radiation-induced Damage to Cardiac Substructures in Breast Cancer Patients and the Protective Strategies

New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease

Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial.

Pathogenesis and Prevention of Radiation-induced Myocardial Fibrosis

Research Progress on the Mechanism, Monitoring, and Prevention of Cardiac Injury Caused by Antineoplastic Drugs—Anthracyclines

Radiation-induced heart disease: a review of classification, mechanism and prevention

Overview of cardiac toxicity from radiation therapy

A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

Research Progress of Radiation Induced Atherosclerosis

Early Cardiotoxicity in Patients Receiving Hypofractionated Radiotherapy after Breast Conserving Surgery: Analysis of a Prospective Study.

Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions

Research Progress in Pathogenesis of Myocardial Fibrosis in Radiation-Induced Heart Damage

Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment

Potential markers and metabolic processes involved in the mechanism of radiation-induced heart injury